Tarsus shareholders elect 4 Class II directors, ratify E&Y as auditor at annual meeting

Tarsus Pharmaceuticals, Inc.

Votes for nominees: Ackermann 10.09M, Azamian 10.22M, Crane 11.04M, Yeu-Lin 10.91M; ~4.27M broker non-votes each.
Ratification of Ernst & Young as auditor approved with 15.32M votes for, 1,027 against, 37 abstain.
Four incumbent directors continue: Link, Chaudhuri, Goldberg, Yarno.

item 5.07

Tarsus Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-178792

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.